NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.

Which medication comes with a risk of severe birth defects?

Bortezomib
Lenalidomide
Bevacizumab
Cetuximab

The correct answer is: Lenalidomide

Lenalidomide is the correct answer because it is associated with a significant risk of severe birth defects if taken during pregnancy. Lenalidomide is a category X medication, meaning that studies in animals or humans have demonstrated fetal abnormalities and/or there is evidence of fetal risk based on human experience. Therefore, it is crucial to avoid pregnancy while taking lenalidomide and to use effective contraception before beginning treatment, during treatment, and for a period of time after treatment has ended. The other options (A. Bortezomib, C. Bevacizumab, D. Cetuximab) do not carry the same level of teratogenic risk as lenalidomide.